{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T11:54:16Z","timestamp":1723290856427},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,4,26]],"date-time":"2012-04-26T00:00:00Z","timestamp":1335398400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Hum Genet"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1038\/jhg.2012.34","type":"journal-article","created":{"date-parts":[[2012,4,26]],"date-time":"2012-04-26T06:18:52Z","timestamp":1335421132000},"page":"358-362","source":"Crossref","is-referenced-by-count":5,"title":["Differences in allele frequencies of autosomal dominant hypercholesterolemia SNPs in the Malaysian population"],"prefix":"10.1038","volume":"57","author":[{"given":"Livy","family":"Alex","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jagdish Kaur","family":"Chahil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Say Hean","family":"Lye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pramod","family":"Bagali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lian Wee","family":"Ler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,4,26]]},"reference":[{"key":"BFjhg201234_CR1","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1517\/14656561003774080","volume":"11","author":"K Toutouzas","year":"2010","unstructured":"Toutouzas, K., Drakopoulou, M., Skoumas, I. & Stefanadis, C. Advancing therapy for hypercholesterolemia. Expert Opin. Pharmacother. 11, 1659\u20131672 (2010).","journal-title":"Expert Opin. Pharmacother."},{"key":"BFjhg201234_CR2","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/ncpcardio0836","volume":"4","author":"AK Soutar","year":"2007","unstructured":"Soutar, A. K. & Naoumova, R. P. Mechanisms of disease: genetic causes of familial hypercholesterolemia. Nat. Clin. Pract. Cardiovasc. Med. 4, 214\u2013225 (2007).","journal-title":"Nat. Clin. Pract. Cardiovasc. Med."},{"key":"BFjhg201234_CR3","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/j.1365-2796.2009.02167.x","volume":"266","author":"SA Mousavi","year":"2009","unstructured":"Mousavi, S. A., Berge, K. E. & Leren, T. P. The unique role of proprotein convertase subtilisin\/kexin 9 in cholesterol homeostasis. J. Intern. Med. 266, 507\u2013519 (2009).","journal-title":"J. Intern. Med."},{"key":"BFjhg201234_CR4","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s00109-007-0172-7","volume":"85","author":"NG Seidah","year":"2007","unstructured":"Seidah, N. G. & Prat, A. The proprotein convertases are potential targets in the treatment of dyslipidemia. J. Mol. Med. (Berl.) 85, 685\u2013696 (2007).","journal-title":"J. Mol. Med. (Berl.)"},{"key":"BFjhg201234_CR5","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nsmb1235","volume":"14","author":"D Cunningham","year":"2007","unstructured":"Cunningham, D., Danley, D. E., Geoghegan, K. F., Griffor, M. C., Hawkins, J. L., Subashi, T. A. et al. Structural and biophysical studies of PCSK9 and its mutants linked to familial hypercholesterolemia. Nat. Struct. Mol. Biol. 14, 413\u2013419 (2007).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"BFjhg201234_CR6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.abb.2003.09.011","volume":"420","author":"S Naureckiene","year":"2003","unstructured":"Naureckiene, S., Ma, L., Sreekumar, K., Purandare, U., Lo, C. F., Huang, Y. et al. Functional characterization of Narc 1, a novel proteinase related to proteinase K. Arch. Biochem. Biophys. 420, 55\u201367 (2003).","journal-title":"Arch. Biochem. Biophys."},{"key":"BFjhg201234_CR7","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.str.2007.04.004","volume":"15","author":"DE Piper","year":"2007","unstructured":"Piper, D. E., Jackson, S., Liu, Q., Romanow, W. G., Shetterly, S., Thibault, S. T. et al. The crystal structure of PCSK9: a regulator of plasma LDL-cholesterol. Structure 15, 545\u2013552 (2007).","journal-title":"Structure"},{"key":"BFjhg201234_CR8","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1073\/pnas.0335507100","volume":"100","author":"NG Seidah","year":"2003","unstructured":"Seidah, N. G., Benjannet, S., Wickham, L., Marcinkiewicz, J., Jasmin, S. B., Stifani, S. et al. The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation. Proc. Natl Acad. Sci. USA 100, 928\u2013933 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFjhg201234_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2008.06.010","volume":"203","author":"G Lambert","year":"2009","unstructured":"Lambert, G., Charlton, F., Rye, K. A. & Piper, D. E. Molecular basis of PCSK9 function. Atherosclerosis 203, 1\u20137 (2009).","journal-title":"Atherosclerosis"},{"key":"BFjhg201234_CR10","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1194\/jlr.M400396-JLR200","volume":"46","author":"F Lalanne","year":"2005","unstructured":"Lalanne, F., Lambert, G., Amar, M. J. et al. Wild-type PCSK9 inhibits LDL clearance but does not affect apoB-containing lipoprotein production in mouse and cultured cells. J. Lipid Res. 46, 1312\u20131319 (2005).","journal-title":"J. Lipid Res."},{"key":"BFjhg201234_CR11","doi-asserted-by":"publisher","first-page":"7100","DOI":"10.1073\/pnas.0402133101","volume":"101","author":"KN Maxwell","year":"2004","unstructured":"Maxwell, K. N. & Breslow, J. L. Adenoviral-mediated expression of PCSK9 in mice results in a low-density lipoprotein receptor knockout phenotype. Proc. Natl Acad. Sci. USA 101, 7100\u20137105 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFjhg201234_CR12","doi-asserted-by":"publisher","first-page":"50630","DOI":"10.1074\/jbc.M410077200","volume":"279","author":"SW Park","year":"2004","unstructured":"Park, S. W., Moon, Y. A. & Horton, J. D. Post-transcriptional regulation of low density lipoprotein receptor protein by proprotein convertase subtilisin\/kexin type 9a in mouse liver. J. Biol. Chem. 279, 50630\u201350638 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFjhg201234_CR13","doi-asserted-by":"publisher","first-page":"11915","DOI":"10.1073\/pnas.0805434105","volume":"105","author":"M Frank-Kamenetsky","year":"2008","unstructured":"Frank-Kamenetsky, M., GreADHorst, A., Anderson, N. N., Racie, T. S., Bramlage, B., Akinc, A. et al. Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates. Proc. Natl Acad. Sci. USA 105, 11915\u201311920 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFjhg201234_CR14","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1194\/jlr.C600025-JLR200","volume":"48","author":"MJ Graham","year":"2007","unstructured":"Graham, M. J., Lemonidis, K. M., Whipple, C. P., Subramaniam, A., Monia, B. P., Crooke, S.T. et al. Antisense inhibition of proprotein convertase subtilisin\/kexin type 9 reduces serum LDL in hyperlipidemic mice. J. Lipid Res. 48, 763\u2013767 (2007).","journal-title":"J. Lipid Res."},{"key":"BFjhg201234_CR15","doi-asserted-by":"publisher","first-page":"5374","DOI":"10.1073\/pnas.0501652102","volume":"102","author":"S Rashid","year":"2005","unstructured":"Rashid, S., Curtis, D. E., Garuti, R., Anderson, N. N., Bashmakov, Y., Ho, Y. K. et al. Decreased plasma cholesterol and hypersensitivity to statins in mice lacking PCSK9. Proc. Natl Acad. Sci. USA 102, 5374\u20135379 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFjhg201234_CR16","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/hep.22354","volume":"48","author":"A Zaid","year":"2008","unstructured":"Zaid, A., Roubtsova, A., Essalmani, R., Marcinkiewicz, J., Chamberland, A., Hamelin, J. et al. Proprotein convertase subtilisin\/kexin type 9 (PCSK9): hepatocyte-specific low-density lipoprotein receptor degradation and critical role in mouse liver regeneration. Hepatology 48, 646\u2013654 (2008).","journal-title":"Hepatology"},{"key":"BFjhg201234_CR17","doi-asserted-by":"publisher","first-page":"E682","DOI":"10.1002\/humu.21002","volume":"30","author":"M Abifadel","year":"2009","unstructured":"Abifadel, M., Rabes, J. P., Jambart, S., Halaby, G., Gannag\u00e9-Yared, M. H., Sarkis, A. et al. The molecular basis of familial hypercholesterolemia in Lebanon: spectrum of LDLR mutations and role of PCSK9 as a modifier gene. Hum. Mutat. 30, E682\u2013E691 (2009).","journal-title":"Hum. Mutat."},{"key":"BFjhg201234_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1567-5688(03)00026-6","volume":"4","author":"JE Dos Santos","year":"2003","unstructured":"Dos Santos, J. E. & Zago, M. A. Familial hypercholesterolemia in Brazil. Atheroscler. Suppl. 4, 1\u20132 (2003).","journal-title":"Atheroscler. Suppl."},{"key":"BFjhg201234_CR19","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/j.1469-1809.2008.00436.x","volume":"72","author":"SE Leigh","year":"2008","unstructured":"Leigh, S. E., Foster, A. H., Whittall, R. A., Hubbart, C. S. & Humphries, S. E. Update and analysis of the University College London low density lipoprotein receptor familial hypercholesterolemia database. Ann. Hum. Genet. 72, 485\u2013498 (2008).","journal-title":"Ann. Hum. Genet."},{"key":"BFjhg201234_CR20","first-page":"7","volume":"28","author":"M Azian","year":"2006","unstructured":"Azian, M., Hapizah, M. N., Khalid, B. A., Khalid, Y., Rosli, A. & Jamal, R. Use of the denaturing gradient gel electrophoresis (DGGE) method for mutational screening of patients with familial hypercholesterolaemia (ADH) and Familial defective apolipoprotein B100 (FDB). Malays. J. Pathol. 28, 7\u201315 (2006).","journal-title":"Malays. J. Pathol."},{"key":"BFjhg201234_CR21","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/clinchem\/43.6.916","volume":"43","author":"ML Choong","year":"1997","unstructured":"Choong, M. L., Koay, E. S., Khoo, K. L., Khaw, M. C. & Sethi, S. K. Denaturing gradient-gel electrophoresis screening of familial defective apolipoprotein B-100 in a mixed Asian cohort: two cases of arginine3500-->tryptophan mutation associated with a unique haplotype. Clin. Chem. 43, 916\u2013923 (1997).","journal-title":"Clin. Chem."},{"key":"BFjhg201234_CR22","first-page":"409","volume":"55","author":"KL Khoo","year":"2000","unstructured":"Khoo, K. L., Van Acker, P., Tan, H. & Deslypere, J. P. Genetic causes of familial hypercholesterolaemia in a Malaysian population. Med. J. Malaysia 55, 409\u2013418 (2000).","journal-title":"Med. J. Malaysia"},{"key":"BFjhg201234_CR23","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1399-0004.1992.tb03653.x","volume":"41","author":"N Saha","year":"1992","unstructured":"Saha, N., Tay, J. S. & Chew, L. S. Influence of apolipoprotein B signal peptide insertion\/deletion polymorphism on serum lipids and apolipoproteins in a Chinese population. Clin. Genet. 41, 152\u2013156 (1992).","journal-title":"Clin. Genet."},{"key":"BFjhg201234_CR24","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1503\/cmaj.051313","volume":"174","author":"G Yuan","year":"2006","unstructured":"Yuan, G., Wang, J. & Hegele, R. A. Heterozygous familial hypercholesterolemia: an underrecognized cause of early cardiovascular disease. CMAJ 174, 1124\u20131129 (2006).","journal-title":"CMAJ"},{"key":"BFjhg201234_CR25","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/ng1201-365","volume":"29","author":"A Brazma","year":"2001","unstructured":"Brazma, A., Hingamp, P., Quackenbush, J., Sherlock, G., Spellman, P., Stoeckert, C. et al. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat. Genet. 29, 365\u2013371 (2001).","journal-title":"Nat. Genet."},{"key":"BFjhg201234_CR26","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/jhg.2010.41","volume":"55","author":"BR Joubert","year":"2010","unstructured":"Joubert, B. R., North, K. E., Wang, Y., Mwapasa, V., Franceschini, N., Meshnick, S.R. et al. Comparison of genome-wide variation between Malawians and African ancestry HapMap populations. J. Hum. Genet. 55, 366\u2013374 (2010).","journal-title":"J. Hum. Genet."},{"key":"BFjhg201234_CR27","doi-asserted-by":"crossref","unstructured":"Boyce, A. J. & Mascie-Taylor, C. G. N. ed. ) Molecular Biology and Human Diversity (Cambridge University Press, Cambridge, UK, 1996).","DOI":"10.1017\/CBO9780511525643"},{"key":"BFjhg201234_CR28","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.arcmed.2005.04.018","volume":"37","author":"L Robles-Osorio","year":"2006","unstructured":"Robles-Osorio, L., Huerta-Zepeda, A., Ordonez, M. L., Canizales-Quinteros, S., D\u00edaz-Villase\u00f1or, A., Guti\u00e9rrez-Aguilar, R. et al. Genetic heterogeneity of autosomal dominant hypercholesterolemia in Mexico. Arch. Med. Res. 37, 102\u2013108 (2006).","journal-title":"Arch. Med. Res."},{"key":"BFjhg201234_CR29","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.atherosclerosis.2010.07.012","volume":"212","author":"AM Medeiros","year":"2010","unstructured":"Medeiros, A. M., Alves, A. C. & Francisco, V. Bourbon M. Update of the Portuguese Familial Hypercholesterolaemia Study. Atherosclerosis 212, 553\u2013558 (2010).","journal-title":"Atherosclerosis"},{"key":"BFjhg201234_CR30","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1101\/gr.172301","volume":"11","author":"CK Garcia","year":"2001","unstructured":"Garcia, C. K., Mues, G., Liao, Y., Hyatt, T., Patil, N., Cohen, J.C. et al. Sequence diversity in genes of lipid metabolism. Genome Res. 11, 1043\u20131052 (2001).","journal-title":"Genome Res."},{"key":"BFjhg201234_CR31","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.ygeno.2003.09.008","volume":"83","author":"MC Ng","year":"2004","unstructured":"Ng, M. C., Wang, Y., So, W. Y., Cheng, S., Visvikis, S., Zee, R. Y. et al. Ethnic differences in the linkage disequilibrium and distribution of single-nucleotide polymorphisms in 35 candidate genes for cardiovascular diseases. Genomics 83, 559\u2013565 (2004).","journal-title":"Genomics"},{"key":"BFjhg201234_CR32","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1159\/000218711","volume":"13","author":"A Adeyemo","year":"2010","unstructured":"Adeyemo, A. & Rotimi, C. Genetic variants associated with complex human diseases show wide variation across multiple populations. Public Health Genomics 13, 72\u201379 (2010).","journal-title":"Public Health Genomics"}],"container-title":["Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/jhg201234.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/jhg201234","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/jhg201234.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:30:27Z","timestamp":1684431027000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/jhg201234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,26]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["BFjhg201234"],"URL":"https:\/\/doi.org\/10.1038\/jhg.2012.34","relation":{},"ISSN":["1434-5161","1435-232X"],"issn-type":[{"value":"1434-5161","type":"print"},{"value":"1435-232X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,26]]}}}